[ad_1]
CEO Sorio, “Corona ‘Found Vaccine Success Ceremony”
Immune effect differs by dose in phase 3 clinical trials
AstraZeneca, low price … Easy to transport and distribute
AstraZeneca’s #CEO expressed confidence in the efficacy, saying it discovered the ‘#successful ceremony’ of the COVID-19 vaccine it is developing. In particular, he said that # severe # serious enough to be hospitalized is 100% preventable.
Pascal Sorio, CEO of AstraZeneca, a multinational pharmaceutical company based in London, United Kingdom, was confident in the success of the Corona 19 vaccine developed with #Oxford University on the 27th (local time).
In an interview with the Sunday Times on Sunday, he said: “We have found a formula for success that can benefit from two doses of the vaccine.”
The reason CEO Sorio emphasized the ‘success formula’ is that the immunity effect was different depending on the dose as a result of the interim analysis of the phase 3 clinical trial of the vaccine.
When the original vaccine was administered twice, the prevention rate was only 62.1%, but when half the dose was administered in the first vaccine due to an error in the experimental process, the prevention rate increased sharply by 90.0%.
When AstraZeneca and the University of Oxford announced their interim clinical results last month, doubts were raised about efficacy due to the #variation by dose # and in the US, the share price fell 3.8% thereafter. that the trial was suspended for 7 weeks.
Chief Executive Officer Sorio said he was surprised when he first discovered that the vaccine’s efficacy was different depending on the dose, and “I hoped people would be disappointed.”
However, he said, “We assessed efficacy positively because it met the standards set by health authorities around the world.”
In an interview for burns at his home in Sydney, Australia, he was confident that “100% of infections are preventable” by corona infections19 that are serious enough to require hospitalization.
The AstraZeneca vaccine has advantages in terms of transportation and distribution because it is cheaper than other vaccines like Pfizer and can be stored in a general refrigerator.
So some observers say that the Pfizer vaccine, which has already been vaccinated, will spread faster if it is approved by British authorities.
The Korean government, which is lagging behind in obtaining vaccines compared to other countries in the world such as the United States and Europe, has signed a contract with AstraZeneca for 20 million doses, so it is closely monitoring the approval decision. of the United Kingdom and the vaccination plan.
Meanwhile, CEO Sorio said AstraZeneca and the University of Oxford are currently working on a new version of the vaccine. I hope it is not necessary, but it is because preparations such as the corona 19 virus variant that appeared in South Africa are necessary.
AstraZeneca and the University of Oxford applied for the emergency use of the Corona 19 vaccine manufactured by both companies to the UK Medical Health Management Products Regulatory Authority (MHRA) on the 21st.
MHRA may announce whether the vaccine is approved for emergency use starting this week, according to foreign outlets such as Bloomberg News.
Fact Korea News = Reporter Donghwan Cha
